Japan picks three Covid-19 drug candidates to get research funds

Japan has selected three candidates for Covid-19 treatments to receive subsidies for clinical trials, according to the health ministry.

According to Reuters, the drugs include AstraZeneca Plc's antibody treatment AZD7442, Shionogi & Co's protease inhibitor S-217622 and Fujifilm Holding Corp's antiviral favipiravir, known commercially as Avigan.

Our readers are at the heart of everything we do.
Do you have a thought to share or a way we can improve? We’d love to hear it. Reach out to us at feedback@dawn.com.

Live Coronavirus

Branded Content

K&N's SmartCooking Recipes: Creamy Tawa Wings with Boiled Rice

Creamy spiced combo wings cooked with tomatoes and aromatic spices served hot with boiled rice.

Pakistan’s first premium plug-in hybrid E-SUV officially hits the roads as Chery Master begins Tiggo 9 PHEV deliveries

This accelerated rollout is backed by the manufacturing strength, operational capability and over 60 years of industrial and automotive legacy of Master Group.

'Where Silence Falls and Survival Speaks': The last guardian of Gabral Valley

In the remote Hindu Kush, Gabral Valley empties each year as winter approaches, leaving behind only one man who stays to guard its frozen silence.

Most Popular

Trump arrives in Beijing for high-stakes meeting with Chinese President Xi

Geopolitical shift in ME

Fuel levy yields lowest fiscal deficit in nearly three decades

US widens drive to revoke citizenship of foreign-born Americans

Flydubai suspends flights to Islamabad, Lahore, Peshawar till Oct due to 'operational issues'

Trump hails Xi talks at grand Beijing banquet attended by leaders, CEOs

Henley places Pakistani passport on 100th spot

Punjab CM Office denies RTI requests seeking details of Maryam's tours and vehicles, luxury jet acquired by govt

After the Raj, the most powerful weapon in Pakistan's arsenal is a name

Latest Stories

Govt has not contacted PPP over any constitutional amendment: Bilawal

Civil servants’ asset declarations to be made public in redacted form, says govt

France, Netherlands say all hantavirus contact cases negative

Pakistan raises $250m equivalent in inaugural Panda bond issuance

Pakistan Business Forum seeks return of agriculture, industry to federal control under proposed 28th Amendment

Aleema Khan moves IHC against PTI founder Imran Khan’s ‘solitary confinement’

Opinion

Towards middle power status

Ishrat Husain

Achieving middle power status requires a robust economic foundation.

Updated 14 May, 2026

Faltering tax effort

Khurram Husain

14 May, 2026

Dangerous depths

F.S. Aijazuddin

14 May, 2026

Judicial disaster

Anwar Mansoor Khan

13 May, 2026

Geopolitical shift in ME

Zahid Hussain

Editorial

Updated 14 May, 2026

Trump in Beijing

China is no longer just a rising economic power.

14 May, 2026

Growing numbers

FORWARD-looking nations do not just celebrate their advantages; they turn them into tangible gains. They also ...

14 May, 2026

No culling

CRUELTY implies an administrative failure to adopt humane solutions. Despite the Lahore High Court’s orders to use...

Updated 13 May, 2026

Unyielding stances

Every day that passes without clarity on how and when the war will end introduces fresh intensity to the uncertainty roiling global markets and adds to the economic turmoil the world must bear because of it.

13 May, 2026